Navigation Links
Validate in Biological Technology

ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions

Testing Will Help Advance Technology to Find a Faster, More Accurate and Repeatable Method for Drug-Particle Sizing PITTSBURGH, April 1 /PRNewswire/ -- ChemImage, ( www.chemimage.com ) today announces a strategic research partnership with Next Breath, LLC ( www.nextbreath.net ), a leading Con...

Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo

CAMBRIDGE, Mass., Sept. 15 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that it has met its second milestone in its option agreement with the Novartis Option Fund and will ...

Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries

Sigma-Aldrich to Provide Full Functional Validation Data for Its MISSION(R) shRNA Collection ST. LOUIS, May 7 /PRNewswire-FirstCall/ -- Sigma-Aldrich(TM) (Nasdaq: SIAL) and the second phase of The RNAi Consortium (TRC2) have commenced functional validation of the Conso...

KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates

Technology to be Applied to Both Clinical- and Preclinical-Stage Compounds in Merck KGaA Pipeline EMERYVILLE, Calif., Aug. 28 /PRNewswire/ -- KineMed, Inc., a pathway-based drug discovery and development company, announced today that it will collaborate with Merck Serono...

Sangamo BioSciences Reports Second Quarter 2009 Financial Results

... ZFP Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics, and the ability to establish strategic partnerships. Further, there can be no assurance that...

Cynosure Reports Second Quarter 2009 Financial Results

...evenue in the second quarter from 30% in the same period of 2008 and 43% in the first quarter of 2009. We believe this increased contribution helps to validate the strategic investments we have made to enhance our overseas infrastructure and broaden our global footprint. In addition, second quarter internati...

BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009

... with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings, Ltd. validate its scientific foundation and the utility of its product candidates. For more information, please visit the Company's Web site at www.biocryst.com ....

Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast

... Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, and whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics. Further, there can be no assurance that the necessary regulatory approvals will be obtained o...

Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders

...pping of a disease passed on from family member to family member, the University's proprietary datasets further accelerate our ability to identify and validate genetic markers that can be used to develop diagnostic tests that allow for a more personalized and a more accurate approach to spine care." ...

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.

...s dangerous spore. Chief Scientist for BioNeutral Group, Inc., Dr. Andy Kielbania stated, "These independent ATS Labs test results completely validate our internal product development efforts. The level of efficacy demonstrated by these independent tests is exceptional. Passing this difficult EPA req...

BioNeutral's Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms

...l. These independent test results stand by themselves and are consistent with our achieving our goals and objectives. These results are incredible and validate all of our efforts." Dr. Philip M. Tierno Jr. MS, PhD Chairman of BioNeutral Group Scientific Advisory Board stated: "The sporocidal data o...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase

...threat and also is one of the most difficult to eradicate spores in the heath care area. These impressive independent lab pre-testing results not only validate our internal results but also give us great confidence that our ongoing EPA registration of our Ygiene(TM) Hospital Grade Antimicrobial will be succes...

Novel handheld device detects anthrax with outstanding accuracy and reliability

..., the new test data being presented this week confirm that the Ceeker is very reliable, enabling front-line decision makers to rapidly and confidently validate initial threat assessments that can ultimately have a far-reaching impact on public safety and well-being. The National Capital Region generally rece...

Data on WaferGen's SmartChip(TM) System to be Presented at 3rd Annual Rediscovering Biomarkers Conference

...Medicine and the University of Texas , Southwestern. These programs are designed to leverage the SmartChip's innovative capabilities to identify and validate therapeutically-relevant gene expression biomarkers in areas including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IP...

Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th

...n as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust discovery program, as well as a multi-pronged approach to validate potential therapeutics; including small molecules, protein biologics, gene therapies and cell-based constructs. The world's first non-profit biotech,...

Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization

...l, chemical and cosmetics industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market. Companies seeking to produce difficult-to-formulate products or to find better methods...

Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma

...siness strategy is to build a highly capital efficient organization that leverages the NIH competitive grant system to offset research expenses and to validate its technology. The model emphasizes strong academic collaborations that lead to the licensing and development of unique products with proof of princi...

Independent U.S. Study Confirms Veritide's Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability

..., the new test data being presented this week confirm that the Ceeker is very reliable, enabling front-line decision makers to rapidly and confidently validate initial threat assessments that can ultimately have a far-reaching impact on public safety and well-being. The National Capital Region generally rece...

Healthy Advice Networks Announces Improved Patient Outcomes in Physicians' Offices with Healthy Advice Programs

...works , "it is critical that patients understand the value of preventative screening and compliance with their treatment recommendations. The results validate what we have always known - patient education drives behavioral change and there is no better place to deliver messages than in the doctor's office." ...

MasterControl and Datafarm Launch GxP2eCTD at the DIA 45th Annual Meeting

...manages a company's critical information throughout the entire product lifecycle. MasterControl software is known for being easy to implement, easy to validate and easy to use. MasterControl solutions include document management, training management, quality management, product lifecycle management, audit man...

Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia

...y difficult patient population to treat. The results represent a clinical proof of concept for elacytarabine as an improved treatment for AML and also validate the potential of our Lipid Vector Technology to produce cancer drugs with enhanced performance. We look forward to continuing the development of elacy...

Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

...brain. The final planned patient in the dosimetry study is currently being enrolled. "These positive data analyzed by a leading dosimetry expert validate a key principle underlying the Cotara program, confirming its ability to specifically concentrate in and deliver a high radiation dose to brain tumors...

BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference

...'s leadership team, each presentation will highlight best practices for improving biospecimen storage, distribution and tracking to protect, prove and validate sample integrity throughout the drug development process. For more information on the event or to register, visit http://www.iirusa.com/bio...

Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C

...nd Australia have showed it is reliable at predicting different degrees of fibrosis in chronic HCV patients. The objective of the present study was to validate the Hepascore test in a U.S. population with chronic HCV infection, and to compare it with two indices that employ nonspecific biomarkers, aspartate a...

Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries

...l, chemical and cosmetics industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market. Companies seeking to produce difficult-to-formulate products or to find better metho...

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

...nt). Using NSCLC cell lines, a genomic profile predicting response to AT-101 was developed in collaboration with Duke University . Opportunities to validate this biomarker will be pursued in future trials. The second presentation reported on an open-label, Phase I/II study of AT-101 in combination wit...

Caprion Proteomics Inc. and Applied Bioystems Work Together to Accelerate Protein Biomarker Verification and Validation

... this week in Philadelphia. Discovery of a significant number of biomarker candidates in academia and industry has created the need to verify and validate these markers in large-scale projects to determine the most promising for clinical development. Caprion specializes in large-scale studies of biomark...

Gene Network Sciences Announces Broad Cancer Collaboration With UCSF and Initial Results

...omputer-driven REFS(TM) platform of GNS. Financial terms of the agreement were not disclosed. GNS and UCSF have utilized REFS(TM) to discover and validate novel mediators of the cell cycle transition, which is a critical determinant of the rate of cancer cell proliferation and tumor growth. These results...

The Hamner Institutes Announce Partnership With China Medical City

...h Triangle Park (RTP), North Carolina, and will focus on preclinical drug development and compliance with FDA regulatory standards. After the partners validate research capabilities and new technologies at The Hamner campus, they will transfer them to China Medical City, a new life science park located in the...

Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States

...n as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust discovery program, as well as a multi-pronged approach to validate potential therapeutics; including small molecules, protein biologics, gene therapies and cell-based constructs. The world's first non-profit biotech,...

City of Baltimore to Evaluate New Generation Biofuels for Use in Boiler Applications

...eneration Biofuels will sell the City biofuel for evaluation in various city municipal buildings. The outcome of the evaluation is expected to further validate New Generation Biofuels' product as a renewable biofuel which uniquely offers NOx and SO2 reductions as compared to traditional distillate products an...

AMT Starts Preregistration Trial for Glybera(TM)

... medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of ...

ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer

...n as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust discovery program, as well as a multi-pronged approach to validate potential therapeutics; including small molecules, protein biologics, gene therapies and cell-based constructs. The Institute's unique, industrial-sc...

Surety, LLC Joins Microsoft BioIT Alliance

...er of its kind within the alliance. Utilizing digital timestamp technology, Surety's solutions allow government and commercial organizations to validate the integrity of their electronic records and help prove their authenticity and intellectual property (IP) ownership when challenged in a competitive ...

Optherion Announces Presentation at ARVO 2009 Annual Meeting

..., Optherion's President and CEO, said: "We are pleased with the results from this prospective clinical study in subjects across a broad age range that validate earlier reports describing the population distribution of genetic markers of AMD. This study assists us in completing the development of a genetic t...

NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer

...ere in the world to be quickly and accurately diagnosed and treated based on each individual's genetic profile. The mission of the NFGC is to validate the concept that molecular signatures in tumors predict cancer risk, diagnosis, prognosis, and response to therapy, as well as to identify new molecul...

Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast

... Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, and whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics. Further, there can be no assurance that the necessary regulatory approvals will be obtained o...

URAC Director of Pharmacy Programs to Speak at Academy of Managed Care Pharmacy Annual Meeting

...marking programs and services that keep pace with the rapid changes in the health care system, and provide a symbol of excellence for organizations to validate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ens...

Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology

...bination with the WAVE platform we are continuing to strengthen our position in high sensitivity genetic analysis. Important publications such as this validate the research and development that we have invested in these technologies." Technical Information Transgenomic's SURVEYOR Nuclease is a prop...

Siemens Focuses on Role-Based, Context-Sensitive, and Knowledge-Driven Solutions at HIMSS 2009

...iological information and tools, now supports an additional workflow step: ' medical check of requests ' helps the radiologist to efficiently plan and validate exam orders. The portal has undergone enhancements that improve usability and include features such as ' peer review ' and improved ' notes viewer ' f...
Other Tags
(Date:11/5/2014)... professor of biology in the UTSA College of ... nation selected to receive a two-year $300,00 National ... Research (EAGER). The funding supports President Obama,s BRAIN ... create new technology that will demystify complex brain ... in neuroscience are broken into the interactions of ...
(Date:11/5/2014)... Brazil -Individuals show great diversity in their ability to ... females greatly differ in their perceptual evaluation of odors, ... tests. , Sex differences in olfactory detection ... may be connected to one,s perception of smell, which ... women,s olfactory superiority has been suggested to be cognitive ...
(Date:11/4/2014)... the right amount of death at the right time ... to new research that could help in understanding animal ... , In a paper in the journal Trends ... and European colleagues conclude that the kind of positive ... of individuals, or mortality, depends on the size and ...
Breaking Biology News(10 mins):UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3The female nose always knows: Do women have more olfactory neurons? 2When less is more: Death in moderation boosts population density in nature 2
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- Many young ... smoke, but a new study finds fumes from the ... been linked to an increased risk for leukemia in ... 21 in the journal Cancer Epidemiology, Biomarkers & ... hookah tobacco smoking is not a safe alternative to ...
(Date:11/22/2014)... Steven Reinberg HealthDay Reporter ... better when patients are treated in an ambulance by a ... researchers report. The sooner patients get the clot dissolver ... after a stroke, the researchers noted. For the best outcome, ... after stroke symptoms start, the researchers said. "The so-called ...
(Date:11/22/2014)... HealthDay Reporter FRIDAY, Nov. 21, ... homes may commonly deal with aggressive or inappropriate behavior from ... 10 centers in New York state found that, in the ... were involved in some type of incident with a fellow ... someone yelling or cursing at another resident. In other cases, ...
(Date:11/21/2014)... Los Angeles, CA (PRWEB) November 21, 2014 ... is now creating picture-perfect smiles for patients in preparation ... are bonded to the fronts of teeth, look completely ... flaws. In certain situations, veneers are also valued for ... for most patients and can be used on one ...
(Date:11/21/2014)... 2014 (HealthDay News) -- Seeking to make it tougher ... and Drug Administration on Thursday approved a new hydrocodone ... -- best known by the brand name Vicodin -- ... to a surge in dangerous addictions across the United ... ER (hydrocodone bitartrate) is an extended-release tablet to treat ...
Breaking Medicine News(10 mins):Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 2Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 3Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3
Other Contents